## STE: STERIS plc (Ireland) - XLV: Healthcare

### Executive Summary

No thesis match: MRS_10 -0.2% below STRENGTH zone (3.0-6.0%); PEG 1.73 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($244.46)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 4
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Oak Thistle LLC Has $808,000 Stock Position in STERIS plc $STE**
- Source: MarketBeat | 20251219T113257 | Somewhat-Bullish | Relevance: 100%
- Oak Thistle LLC significantly reduced its holdings in STERIS plc (NYSE:STE) by 80.3% in the third quarter, bringing its position to $808,000. Despite this reduction, several other institutional investors increased their stakes in STERIS, and the company maintains a "Moderate Buy" analyst consensus with an average price target of $273.50. STERIS recently announced a quarterly dividend and reported strong financial results, beating analyst expectations for earnings per share and revenue.

**2. Assenagon Asset Management S.A. Boosts Position in STERIS plc $STE**
- Source: MarketBeat | 20251218T090030 | Bullish | Relevance: 100%
- Assenagon Asset Management S.A. significantly increased its stake in STERIS plc (NYSE:STE) during the third quarter, adding 249,386 shares to reach a total of 330,907 shares valued at $81.88 million. This move comes as STERIS reported strong Q3 earnings, beating analyst expectations for both EPS and revenue, and issued optimistic FY2026 guidance. The company also declared a quarterly dividend of $0.63 per share, representing an annualized yield of 1.0%.

**3. Will STERIS plc stock see insider buying - Gap Down & Breakout Confirmation Alerts**
- Source: Улправда | 20251219T015721 | Neutral | Relevance: 100%
- This article briefly mentions STERIS plc stock in conjunction with promotional material for an "Investment Community" platform promising high returns on small investments. It also includes unrelated news about Stellar's investment in the Soroban smart contract platform and the Hong Kong Education Bureau's study tours to mainland China for teachers. The core content seems to be a fragmented collection of promotional messages and disparate news items.

**4. Sotera Health Looks Undervalued, Analyst Says - Sotera Health (NASDAQ:SHC)**
- Source: Benzinga | 20251218T190945 | Somewhat-Bullish | Relevance: 73%
- William Blair initiated coverage on Sotera Health (NYSE: SHC) with an Outperform rating, noting the company appears undervalued despite its strong market position and best-in-class margins. The analyst believes easing ethylene oxide litigation risks and improving free cash flow will lead to a re-rating of the stock, predicting approximately 45% upside over the next two years. Sotera Health's integrated sterilization platform and sticky customer base are highlighted as key strengths.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 11 ($0.79M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (+0.4%)
- Blackrock Inc.: 8.9% (+1.3%)
- Massachusetts Financ: 4.9% (-7.7%)
- State Street Corpora: 4.4% (+4.0%)
- Morgan Stanley: 4.3% (+8.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.73 elevated, pricing in significant growth expectations. Forward P/E 22.9x stretched relative to 9% growth. Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.48). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $25.1B |
| Beta | 1.01 |
| 52W Range | $200.98 - $268.60 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.73 |
| Forward P/E | 22.9 |
| Current P/E | 25.0 |
| YoY Growth | 9.1% |
| EPS Direction | STABLE |

### Technicals

MRS_10 stable at -0.2% (minimal 5-day change). Below STRENGTH zone by 3.2pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). MACD histogram bearish (-1.33), momentum weakening. RSI neutral at 48. OFD pattern: +MTH (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.21% (CS: 50) | Neutral |
| RSI_14 | 47.8 | Neutral |
| MACD Histogram | -1.33 | Bearish |
| vs SMA20 | 0.983x | Below |
| vs SMA50 | 1.010x | Above |
| vs SMA200 | 1.063x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $254.50
- **Stop Loss:** $244.46 (3.9% risk)
- **Target:** $264.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 119
- **Position Value:** $30,285.50
- **Portfolio %:** 30.29%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite as VIX falls to 6th percentile and tech rally resumes on AI infrastructure demand. Fed pause expectations from cooling CPI data support equities, though elevated put/call ratio suggests cautious positioning. Focus on quality names in AI-exposed sectors.*

### Earnings

**Next:** 2026-02-04 (Est: $2.53)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.35 | $2.47 | +5.1% |
| 2025Q2 | $2.26 | $2.34 | +3.4% |
| 2025Q1 | $2.60 | $2.74 | +5.4% |
| 2024Q4 | $2.32 | $2.32 | -0.1% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*